Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns
The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.
Perfuze celebrates a ‘major milestone’ for new-look stroke catheter
The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Mediterranean diets that include some lean red meat can still boost cardiovascular health
The study's authors focused on blood pressure reductions and arterial stiffness, sharing their findings in Current Developments in Nutrition.
Late-breaking cardiovascular drug trials took center stage at ACC.25
Richard Kovacs, MD, detailed some the most important late-breaking cardiology pharmacology trials presented at ACC.25.

Medtronic recalls a second directional atherectomy device due to risk of tip damage

There have been no incidents at this time, but the device is similar to another Medtronic solution that was recently recalled.

New scoring system predicts stroke risk after COVID-19

The study's authors said some of their findings surprised them.

New clot-busting stroke drug lowers risk of serious complications

Alteplase is currently seen as the standard of care for stroke treatment among many clinicians, but tenecteplase offers significant value.

Risk of COVID-related stroke highest soon after diagnosis

“These findings can inform diagnosis, treatment and care of stroke among patients with COVID-19,” one researcher said.

What decades of data tell us about stroke rates in the U.S.

Researchers tracked 29 years of data, uncovering a mix of good news and concerning trends.

Carotid endarterectomy may be a safer treatment option than carotid artery stenting

Researchers reviewed 26 years of data, sharing their findings in the European Journal of Vascular & Endovascular Surgery.

Endovascular therapy less likely among Black stroke patients

Access to endovascular therapy does not appear to be the issue.

A fresh look at managing patients with type B aortic dissection

The new guideline calls for a “stepwise approach," followed by close clinical surveillance, when treating uncomplicated TBAD. In some cases, however, earlier endovascular treatments may be necessary.

Vascular & Endovascular

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

Perfuze celebrates a ‘major milestone’ for new-look stroke catheter

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Mediterranean diets that include some lean red meat can still boost cardiovascular health

Late-breaking cardiovascular drug trials took center stage at ACC.25